Tamoxifen is an oral anti-estrogen used to treat women with estrogen receptor positive breast cancer. It is taken once daily and blocks the estrogen receptor on cancer and normal cells. It ...

Claimed as the biggest breakthrough in treatment for 20 years, it is the first drug to challenge tamoxifen, the standard treatment for postmenopausal women after surgery. Trial results out ...

In the daily group, 41 participants received a 20 mg dose of tamoxifen each day. In the weekly group, tamoxifen at the same dose was administered once per week after an initial 8-week period of ...

Tamoxifen (Nolvadex, Soltamox) is the most widely prescribed breast cancer therapy in the world. Some even call it the "backbone" of breast cancer treatment. Even with all that fanfare, tamoxifen ...

Tamoxifen treatment has been linked to an excess risk of nonalcoholic steatohepatitis, which is characterized by inflammation and fatty deposits in the liver. Bruno and colleagues have ...

Background: Tamoxifen is standard adjuvant treatment for postmenopausal women with hormone-receptor-positive breast cancer. We assessed the benefit of adding chemotherapy to adjuvant tamoxifen and ...

[20] In particular, it was observed that anastrozole users had poorer visual and verbal learning and memory performance than women receiving tamoxifen. Although controlling for breast cancer ...